109 results found.
          
DePuy Synthes Reports 2Q18 Orthopaedic Revenue -1.4% YoY
DePuy Synthes reported 2Q18 orthopaedic revenue of US $2,261.0MM, -1.4% vs. 2Q17, and 1H18 revenue of 
Stryker's David Floyd Retiring; Leadership Changes Occur
David Floyd, Group President of Orthopaedics at Stryker, will retire on June 30, 2019.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
DePuy Synthes Reports 1Q18 Orthopaedic Revenue
DePuy Synthes reported 1Q18 orthopaedic revenue of US $2,250.0MM, -1.1% vs. 1Q17.
Smith & Nephew Appoints Namal Nawana as CEO
Smith & Nephew has appointed Mr. Namal Nawana as Chief Executive Officer and successor to Mr. Olivier Bohuon, effective May 2018.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
OrthoPediatrics Posts 4Q17 and 2017 Revenue Growth Over 20%
OrthoPediatrics posted 4Q17 revenue of US $11.7MM, +23.7% vs. 4Q16, and 2017 revenue of $45.6...
Anika Therapeutics' 4Q17 and 2017 Orthobiologic Revenue
Anika Therapeutics posted 4Q17 orthobiologic revenue of US $25.1MM, +3.1% vs. 4Q16, and 2017 revenue of
DePuy Synthes Reports 4Q17 and 2017 Revenue
ORTHOWORLD estimates DePuy Synthes’ 4Q17 orthopaedic revenue at US $2,245.7MM, +0.3% vs. 4Q16, with 2017 revenue of $8,7...
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
DePuy Synthes 3Q17 Orthopaedic Revenue +0.5% YoY
ORTHOWORLD estimates DePuy Synthes’ 3Q17 orthopaedic revenue at US $2,120.6MM, +0.5% vs. 3Q16, with 9 months 2017 revenue of ...
Smith & Nephew CEO Announces Retirement; Acquisition Buzz Returns
Smith & Nephew's Chief Executive Officer, Olivier Bohuon, announced his intention to retire by the end of 2018 after seven years in the positio...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Alphatec Spine Reports 2Q17 Revenue
Alphatec Spine posted 2Q17 revenue of US $24.4MM, -24.4% vs. 2Q16, and 1H17 revenue of $52.4MM, -21.2% vs. ...
Anika Therapeutics Posts Orthobiologics Sales Growth for 2Q17/1H17
Anika Therapeutics posted 2Q17 orthobiologic revenue of US $24.5MM, +5.0% vs. 2Q16, and 1H17 revenue of
DePuy Synthes 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
Anika Therapeutics to Log $5MM Milestone Payment for MONOVISC
Anika Therapeutics will receive a US $5MM milestone payment per terms of the MONOVISC® license agreement
David Dvorak Departs as Zimmer Biomet CEO
Zimmer Biomet announced the departure of David Dvorak, its CEO of ten years. Dan Florin, Senior Vice President and CFO,...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Anika Therapeutics Posts 1Q17 Orthobiologic Revenue
Anika Therapeutics posted 1Q17 orthobiologic revenue of US $20.2MM, +3.3% vs. 1Q16. 
Wright Medical's 1Q17 Revenue
Wright Medical reported 1Q17 revenue of US $177.2MM, +4.7% from 1Q16. (U.S. $132.1MM, +6.1%; ex-U.S. $45.0MM, +0.6%
Globus Medical Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Globus Medical in the interim, pl...
Zimmer Biomet 1Q17 Orthopaedic Revenue
ORTHOWORLD estimates Zimmer Biomet 1Q17 orthopaedic revenue of US $1,836.1MM, +4.9% from 1Q16.
Zimmer Biomet Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Zimmer Biomet in the interim,
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group